| Business Summary | | Hemagen
Diagnostics,
Inc.
develops,
manufactures
and
markets
proprietary
medical
diagnostic
test
kits
(assays)
used
to
aid
in
the
diagnosis
of
autoimmune
and
infectious
diseases,
in
general
health
assessment
and
for
research
purposes.
Hemagen
also
develops,
manufactures
and
markets
materials
for
the
manufacture
of
diagnostic
test
kits.
Hemagen
offers
approximately
148
test
kits
that
have
been
cleared
by
the
FDA
for
sale
in
the
United
States.
Hemagen
markets
and
sells
its
brand
name
products
worldwide,
directly
through
its
sales
force
and
through
national
and
international
distributors.
It
markets
its
products
in
South
America
through
its
majority-owned
subsidiary,
Hemagen
Diagnosticos
Comercio,
Importacao
e
Exportacao,
Ltd.,
a
Brazilian
limited
liability
company.
In
addition,
Hemagen
sells
certain
of
its
products
on
a
private-label
basis
to
multinational
distributors
of
medical
diagnostic
products. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Hemagen
Diagnostics,
Inc.
is
a
biotechnology
company
which
develops,
manufactures
and
markets
laboratory
medical
diagnostic
kits
used
to
aid
in
the
diagnosis
of
certain
autoimmune
and
infectious
diseases.
For
the
nine
months
ended
6/30/01,
revenues
rose
5%
to
$8.5
million.
Net
loss
before
acct.
change
fell
82%
to
$532
thousand.
Revenues
reflect
increased
sales
at
the
Raichem
division.
Lower
loss
also
benefitted
from
head
count
reductions
and
cost
saving
efforts. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| William Hales, 38 Pres | $150K | -- | Deborah Ricci, 36 CFO,
VP | 76K | -- | Ricardo De Oliveira, M.D., 49 VP
of R&D | 120K | $1.2K | Dollar amounts are as of 30-Sep-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|